ThursdayMar 31, 2022 9:15 am

reBLOCKmiami to Showcase Top Trends and Where Real Estate, Crypto, and Blockchain Spaces Meet

On April 5, 2020, beginners, advocates (anyone interested in moving the real estate blockchain space forward), and professionals making a mark in the real estate sector – developers, brokers, traders, policymakers, financiers, startups, and agents – will congregate at the magnificent Hilton Miami Airport Blue Lagoon hotel for the reBLOCKmiami event, set to run from 8.30 am through 5.00 pm. The goal is to learn and network, focused on real estate blockchain, tokenization, non-fungible tokens (“NFTs”), and fintech startups, as well as Decentralized Finance (“DeFi”) real estate, regulatory updates, tradeable private real estate, and buying property in the metaverse. The…

Continue Reading

ThursdayMar 31, 2022 9:15 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Inks Retail Partnership with BESTIES Vegan Paradise to Strengthen its Retail Footprint and Product Offering

The partnership will see the rebranding of XMarket brick-and-mortar stores in Venice, and Hillcrest, California, under the BESTIES brand PlantX is confident that its partnership with BESTIES will accelerate the already significant growth for PlantX In the first month of the rebrand, PlantX posted a 30% growth in sales revenue Over the past year, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has embarked on an aggressive expansion campaign to strengthen its retail footprint and bring its products and services closer to consumers. This has seen the opening of various XMarket brick-and-mortar stores in strategic locations, the launch of shop-in-shops…

Continue Reading

ThursdayMar 31, 2022 9:15 am

Facebook’s Former Head of Advertising Joins NobleCon18 Lineup

Noble Capital Markets has announced that Rob Goldman will be a featured Metaverse panelist at NobleCon18, which feature presentations from 120 public companies on April 20 and 21 at The Guitar Hotel near Miami, FL. Joining Facebook (NASDAQ: FB) in 2012 reporting directly to CEO Mark Zuckerberg, Goldman was charged with growing and monetizing the burgeoning social media platforms (including subsidiaries such as Instagram). During his tenure at Facebook, revenues grew from $5 billion to over $70 billion in a span of seven years.  Goldman’s move to Facebook happened when his company, Threadsy, was acquired by the social media giant…

Continue Reading

ThursdayMar 31, 2022 9:00 am

Hero Technologies Inc. (HENC) Subsidiary Establishes Presence in Booming Colorado Cannabis Market

Cannabis sales in Colorado broke another record last year, topping $2.22 billion in products sold Cannabis is “massive” driver of tax revenue for Colorado, raking in over $423 million last year alone HENC continues to pursue diversification and integration strategy through subsidiary Another record-breaking year for Colorado’s cannabis industry bodes well for Hero Technologies (OTC: HENC). The company anticipates expanding into the booming market via cultivation and dispensary operations through its wholly owned subsidiary, Mile High Green LLC.  Cannabis sales in the state broke another record last year, topping $2.22 billion in products sold, according to the Colorado Department of Revenue (https://ibn.fm/NNChl). This figure…

Continue Reading

ThursdayMar 31, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Reiterates Commitment to Operational Excellence, Advancing Berubicin Recognition

In a video message to shareholders, CEO John Climaco detailed the operational and clinical progress made by lead drug candidate Berubicin despite market volatility and share price fluctuations CNS is currently enrolling patients into a potentially pivotal global drug trial of Berubicin for recurrent glioblastoma multiforme Interim analysis of the trial is currently expected as early as the first quarter of 2023, once 30-50% of trial patients have been on the study for six months CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotech company specializing in developing novel treatments for primary and metastatic cancers of the brain and central nervous system,…

Continue Reading

WednesdayMar 30, 2022 2:39 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Poised to Increase Overall Value on the Lightning Network

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, recently deployed additional European routing nodes. “The company’s available European routing nodes include Italy, Sweden, England, Ireland, France, and Germany. Europe contains approximately 43% of all Lightning Network nodes – second to North America,” a recent article reads. Since the November 2021 launch of the first routing node, US-West, LQwD has seen 157 nodes interconnected with more than 158 transaction channels, routing over 10 Bitcoin through these channels. “LQwD’s launch of these additional nodes firmly positions us to increase…

Continue Reading

WednesdayMar 30, 2022 2:27 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 24th Patent Sets the Stage for New Market Opportunities in Australia

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, celebrated the receipt of its 24th granted patent entitled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof.” Granted in Australia, this is the first patent awarded from the company’s 8th patent family. “The new patent expands on the company’s international IP rights to apply DehydraTECH(TM) technology to most forms of nicotine, namely sprays, gums, lozenges, pouches, capsules, tablets, and pills. It also covers multiple disparate forms of nicotine, including polymer resins of nicotine, freebase nicotine and other nicotine complexes,” reads a recent article. Prior to the…

Continue Reading

WednesdayMar 30, 2022 1:46 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Releases Spring 2022 Robot Roadshow Schedule

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced its spring 2022 Robot Roadshow schedule. Designed to be an engaging experiential event that allows Knightscope to connect with potential clients and showcase its proprietary crime-fighting robots, the Robot Roadshow will begin on April 12, 2022, and will tour 10 states, including Minnesota, Wisconsin, Illinois, Indiana and Ohio, with 35 scheduled stops. The roadshow will also be in Washington, D.C. during National Police Week. Creative marketing events such as the Robot Roadshow allow KSCP, a public safety innovator, to educate existing and…

Continue Reading

WednesdayMar 30, 2022 1:34 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Host LD Micro Invitational at Four Seasons Westlake Village

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced that it will host the 2022 LD Micro Invitational. The prominent three-day investor conference is slated to take place on June 7-9, 2022, at the Four Seasons Hotel Westlake Village, California. Approximately 200 companies from all over the world will showcase what makes them truly special at the event, each presenting for 25 minutes and finalizing their exhibition with private meetings. SRAX will soon release the link to register for virtual and physical components of the…

Continue Reading

WednesdayMar 30, 2022 12:58 pm

QualityStocksNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Subsidiary Expands Treatment Options to Add FDA-Approved Esketamine Nasal Spray

Delic Holdings’ (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) subsidiary, Ketamine Wellness Centers (“KWC”), the largest ketamine therapy provider in the U.S., has expanded its treatment options to include SPRAVATO(R) nasal spray. KWC clinics located in Houston, Las Vegas and Seattle will begin offering this treatment option on April 1. According to the announcement, SPRAVATO is taken with an oral antidepressant and is the first FDA-approved esketamine nasal spray for adults with treatment-resistant depression (“TRD”) or to treat depressive symptoms in adults with major depressive disorder (“MDD”) with suicidal thoughts or actions. Patients interested in the treatment option will first undergo…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered